Key facts
- Agteria Biotech’s last known valuation is $21.8M (Feb 2025).
- It has raised $7.7M; the latest was Seed Round ($6.2M) in Feb 2025.
- Notable investors include Industrifonden, AgriZeroNZ, KTH Innovation, MIT Climate & Energy Prize, Mudcake — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Agteria Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Agteria Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Agteria Biotech
Developer of sustainable feed additives designed to reduce methane emissions from cows. The company offers a feed additive designed to improve the overall health and well-being of livestock while reducing methane emissions, which contributes to a more sustainable livestock farming industry, enabling customers to enhance the health of animals, potentially leading to productivity and reduced need for antibiotics.
- Sector
- Materials and Resources
- HQ
- Stockholm, Sweden
- Founded
- 2023
- Employees
- 10
- Website
- agteria.com/
- Ownership
- Privately Held (backing)
Agteria Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Agteria Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Agteria Biotech in its N-PORT filings yet. We sweep new filings monthly.